A Regulatory Post-marketing Surveillance (rPMS) Study to Evaluate the Safety and Effectiveness of Saxenda®(Liraglutide 3.0 mg) in Obese Patients and Overweight Patients With Obesity-related Comorbidities in Routine Clinical Practice in Korea.
Clinical trial NCT03560336 · COMPLETED
Trial details
- NCT number
- NCT03560336
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-07-05
- Primary completion
- 2020-12-02
- Enrollment
- 758
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.